Neonatal hypoxic-ischemic encephalopathy (HIE) is the leading cause of neonatal encephalopathy (NE) and is associated with multi-organ dysfunction (MOD) and long-term complications.1 The impact of oxygen deprivation and redistribution of cardiac output to vital organs is likely higher in preterm neonates (born before 35 weeks of gestation) with the added burden of hypoxia and immaturity.2 Studies typically focus on term infants, due to limitation of the neurological assessment in preterm examination and lack of therapeutic options in vulnerable preterm group.3
We aim in this brief communication to compare the incidence of and severity of MOD term versus preterm infants. We leverage a prospective neuronicu registry started in 2009 with strict protocols in all infants with suspected HIE to measure laboratory end organ measures for hepatic (AST and ALT), cardiac (troponin and echocardiography), and renal (creatinine and oliguria, based on KDIGO score) injury at birth and prior to discharge.4
Using American Academy of Pediatrics (AAP) established criteria to define HIE,5 we examined all charts with HIE diagnosis between January 2009 and 2023. Laboratory definitions of MOD included: hepatic injury (AST or ALT > 100 U/L), cardiac injury (troponin T > 0.1 ng/mL and/or abnormal echocardiography), and renal dysfunction (KDIGO-based classification for creatinine and oliguria4). Statistical comparisons between term and preterm infants (<36 weeks gestation) were performed using non-parametric testing (Wilcoxon rank-sum test), with p < 0.05 considered significant. All analyses were completed in R (v4.4.0) under institutional IRB approval, following STROBE guidelines.
Of 135,708 live births during the study period, 506 infants were diagnosed with HIE—452 term and 54 preterm (Fig. 1). Preterm infants under 36 weeks gestation accounted for 10% of all birth in this cohort, characteristics summarized in Table 1. The incidence of HIE diagnosis was similar in both groups at 3/1000. Our results reveal contrasting outcomes based on gestational age including higher risk for seizures. Mortality was significantly higher among preterm infants (18% vs. 9%). Multiorgan dysfunction (MOD) was also more prevalent in preterm (80% vs. 57%). Hepatic injury emerged as the most frequent abnormality in both groups (67% in preterm vs. 57% in terms), followed by cardiac (55% vs. 55%) and renal (37% vs. 44%) injuries. Notably, organ involvement was not only more frequent but also more severe in preterm infants. Median AST values on day one were more than twice as high in preterm (277 vs. 130 U/L), and troponin T levels similarly reflected greater myocardial stress (0.3 vs. 0.23 ng/mL). The resolution of organ injury biomarkers was slower in the preterm group.
Furthermore, the involvement and burden of multiple organs were significantly greater in preterm (39% vs. 13%). This also included Brain MRI which demonstrated 83% abnormal findings in preterm vs 60% in term infants. The watershed and basal ganglia lesions pathognomonic of HIE injury were similar in term and preterm (17% vs 18%), while preterm infants demonstrated added lesions as intraventricular hemorrhage, cerebellar hemorrhages and isolated white matter injury predominant white matter and cortical injury.6 These results suggest a differential vulnerability of the developing brain and other organ systems to hypoxic insult based on gestational age.
Collectively, our findings indicate that MOD in HIE disproportionately affects preterm infants. The increased systemic burden may reflect a combination of factors: immature organ development, reduced autoregulatory capacity, and heightened vulnerability to inflammation and infection.7 Preterm neonates also lack robust collateral circulatory mechanisms and are less capable of redistributing cardiac output in response to hypoxia, which may exacerbate systemic injury.
We confirm the cerebral vulnerabilities with preterm infants demonstrating a more diffuse pattern with bleeding, possibly due to altered cerebrovascular autoregulation and developmental susceptibilities.8 While most infants demonstrated resolution of overt organ dysfunction by discharge, persistent elevations in troponin and creatinine were observed among preterm survivors, suggesting possible ongoing subclinical cardiac and renal stress. These likely contribute to the developmental origins of adult disease (DOHAD) observations postulating early repetitive insult during critical periods of brain development to contribute to later developmental, cardiovascular, and metabolic outcomes through the life span. These data underscore the need for longitudinal organ-specific monitoring, particularly in preterm infants. They also highlight the limitations of an exclusively neurocentral framework for evaluating and managing HIE.
This emerging evidence challenges the prevailing therapeutic paradigm in HIE, which remains largely focused on term infants. The concept of “encephalopathy of prematurity” must expand to include the systemic multiorgan involvement.
Our findings suggest that preterm neonates although less than 10% of births have equal incidence and higher burden from HIE, in fact, represent a subgroup in greater need of systemic protective strategies.9 A more inclusive research approach is warranted in preterm newborns to investigate therapies that mitigate MOD alongside neurologic injury.8
Future research must validate our findings across diverse populations, include long-term follow-up of systemic and neurodevelopmental outcomes, and evaluate targeted interventions that may modulate MOD. It is also imperative that future classification systems for HIE incorporate multiorgan data—potentially redefining severity not solely based on clinical encephalopathy, but also on systemic indicators of physiologic stress.
In conclusion, our data reveal a disproportionate burden of MOD in preterm infants with HIE. Gestational age appears to be a crucial determinant of both vulnerability and recovery, with significant implications for diagnosis, prognostication, and therapeutic development. A paradigm shift toward integrated, gestational age–specific, multiorgan care strategies is essential for optimizing outcomes in this vulnerable population.10
References
Bitar, L., Leon, R. L., Liu, Y.-L., Kota S. Chalak, L. F. Multi-organ dysfunction across the neonatal encephalopathy spectrum. Pediatr. Res. 1–7 https://doi.org/10.1038/s41390-025-03978-2 (2025).
Pavageau, L., Sanchez, P. J., Steven Brown, L. & Chalak, L. F. Inter-rater reliability of the modified Sarnat examination in preterm infants at 32-36 weeks’ gestation. Pediatr. Res. 87, 697–702 (2020).
Volpe, J. J. et al. Brain injury in premature infants: a complex amalgam of destructive and developmental disturbances. Lancet Neurol. 8, 110–124 (2009).
Khwaja, A. et al. KDIGO clinical practice guideline for acute kidney injury. Kidney Int. Suppl. 2, 1–138 (2012).
American Academy of Pediatrics Committee on Fetus and Newborn. Neonatal encephalopathy and neurologic outcome, second edition. Pediatrics 133, e1482–e1488 (2014).
Sweetman, D. U. et al. Multi-organ dysfunction scoring in neonatal encephalopathy (MODE Score) and neurodevelopmental outcomes. Acta Paediatr. 111, 93–98 (2022).
Back, S. A. et al. White matter injury in the preterm infant: pathology and mechanisms. Acta Neuropathol. 134, 331–349 (2017).
Faix, R. G. et al. Whole-body hypothermia for neonatal encephalopathy in preterm infants 33 to 35 weeks’ gestation: a randomized clinical trial. JAMA Pediatr. 179, 396–406 (2025).
Bitar, L. et al. Multi-organ involvement in preterm neonatal encephalopathy. Early Hum. Dev. 208, 106317 (2025).
Molloy, E. J. et al. Neuroprotective therapies in the NICU in preterm infants: present and future (Neonatal Neurocritical Care Series). Pediatr. Res. 95, 1224–1236 (2024).
Acknowledgements
Dr Chalak is supported by PCORI, Crystal Charity Ball UT Foundation, R01 NINDS R01 NS102617. Dr Chalak wrote, reviewed, and finalized the Submission. Lynn Bitar co first author was responsible of the first draft and of data completion, Paywand Baghal and Khawar Nawaz helped with data collection, Srinivas Kota performed statistics and finalized the figures. All authors reviewed and participated in the manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
About this article
Cite this article
Chalak, L.F., Bitar, L., Baghal, P. et al. Multiorgan impact of neonatal encephalopathy: higher burden in preterm infants. Pediatr Res (2025). https://doi.org/10.1038/s41390-025-04617-6
Received:
Accepted:
Published:
Version of record:
DOI: https://doi.org/10.1038/s41390-025-04617-6
